Skip to content
Contact

Partnerships

IMU Powers Drug Discovery & Clinical Breakthroughs

IMU® collaborates with clinical research groups, pharmaceutical, biotech and diagnostics companies to identify and deploy clinically actionable immune signatures that advance precision medicine.

Partnering with IMU

01

Decode Disease Biology

  • Discovery of novel immune signatures of disease
  • Discovery of mechanistic insights into treatment success, resistance and toxicity
  • Identification of new therapeutic targets and immune-driven pathways
  • Identification of biomarkers for early diagnosis and disease endotyping

02

Optimise Clinical Development

  • Prediction of likely responders and non-responders
  • Enablement of patient stratification and selection to improve trial outcomes
  • Identification of biomarkers for study design and endpoint selection
  • Prediction and monitoring of immune-related adverse events

03

Advance Precision Medicine

  • Development of biomarker-driven diagnostics
  • Improved donor selection for transplantation 
  • Personalised drug selection, drug titration and patient monitoring
  • Delivery of companion diagnostics for clinical implementation

Contact us to Explore Partnering With IMU